tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CytoSorbents Faces Regulatory Challenges for DrugSorb-ATR
PremiumCompany AnnouncementsCytoSorbents Faces Regulatory Challenges for DrugSorb-ATR
2M ago
CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR
Premium
The Fly
CytoSorbents provides FDA, Health Canada regulatory update for DrugSorb-ATR
2M ago
CytoSorbents Appeals FDA Denial of DrugSorb-ATR
Premium
Company Announcements
CytoSorbents Appeals FDA Denial of DrugSorb-ATR
2M ago
Cytosorbents Hold Rating: Navigating Revenue Declines, Regulatory Challenges, and Strategic Uncertainties
PremiumRatingsCytosorbents Hold Rating: Navigating Revenue Declines, Regulatory Challenges, and Strategic Uncertainties
3M ago
CytoSorbents Reports Q1 2025 Financials and Strategic Updates
Premium
Company Announcements
CytoSorbents Reports Q1 2025 Financials and Strategic Updates
3M ago
CytoSorbents reports Q1 EPS (2c) vs. (11c) last year
Premium
The Fly
CytoSorbents reports Q1 EPS (2c) vs. (11c) last year
3M ago
Cytosorbents’ Neutral Rating Amid Revenue Shortfall and Strategic Reorganization
PremiumRatingsCytosorbents’ Neutral Rating Amid Revenue Shortfall and Strategic Reorganization
5M ago
Cytosorbents Corp Reports Strong Growth Amid Challenges
Premium
Company Announcements
Cytosorbents Corp Reports Strong Growth Amid Challenges
5M ago
CytoSorbents Corporation Reports Strong 2024 Performance
Premium
Company Announcements
CytoSorbents Corporation Reports Strong 2024 Performance
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100